Yigeng Feng
Longhua, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Qiling decoction enhances the anti-tumor activity of abiraterone acetate by up-regulating miR-143 expression in abiraterone acetate-resistant prostate cancer cells.
Journal: Frontiers in medicine
Published: June 09, 2025
Neuregulin-1 correlates to early castration-resistant prostate cancer after prostate cancer patients receiving androgen deprivation therapy.
Journal: Journal of Cancer
Published: February 27, 2025
Stachydrine hydrochloride induces cell senescence and ferroptosis of castration-resistant prostate cancer.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: February 11, 2025
The Deubiquitinating Enzyme USP46 Abolishes Cell Survival of Prostate Cancer via Enhancing BECN1-Dependent Autophagy.
Journal: Biotechnology and applied biochemistry
Published: January 08, 2025
Zhoushi Qiling decoction inhibits neuregulin 1 secreted from cancer-associated fibroblasts to ameliorate enzalutamide resistance in prostate cancer.
Journal: Journal of traditional and complementary medicine
Published: August 14, 2024
NRG1 secreted by cancer-associated fibroblasts contributes to enzalutamide resistance in prostate cancer cells.
Journal: American journal of cancer research
Published: April 25, 2024
STL127705 synergize with olaparib in castration-resistant prostate cancer by inhibiting homologous recombination and non-homologous end-joining repair.
Journal: American journal of cancer research
Published: February 13, 2023
JNK promotes the progression of castration-resistant prostate cancer.
Journal: Acta biochimica Polonica
Published: January 11, 2023
Zhoushi Qi Ling decoction inhibits the progression of castration-resistant prostate cancer in vivo by regulating macrophage infiltration via IL6-STAT3 signaling.
Journal: Journal of traditional and complementary medicine
Published: December 15, 2022
Last Updated: 09/26/2026